Search research articles
Contact Us
Filters
Showing results (351-360 of 407) with videos related to
Page
of 41
Sort By:
Brain Research
|
September 6, 1988
Non-chromaffin tissue plus nerve growth factor reduces experimental parkinsonism in aged rats
G Pezzoli, S Fahn, A Dwork, et al.
Archives of Neurology
|
December 1, 1996
Use of intrathecal baclofen in the treatment of patients with dystonia
B Ford, P Greene, E D Louis, et al.
Advances in Neurology
|
September 29, 1998
Intrathecal baclofen in the treatment of dystonia
B Ford, P E Greene, E D Louis, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism
|
September 1, 1993
Striatal 18F-dopa uptake: absence of an aging effect
D Eidelberg, S Takikawa, V Dhawan, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
January 1, 1994
A multicenter double-blind placebo-controlled trial of pergolide as an adjunct to Sinemet in Parkinson's disease
C W Olanow, S Fahn, M Muenter, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience
|
May 1, 1992
Transgenic mice with increased Cu/Zn-superoxide dismutase activity are resistant to N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurotoxicity
S Przedborski, V Kostic, V Jackson-Lewis, et al.
Muscle & Nerve
|
July 1, 1991
Distant effects of locally injected botulinum toxin: a double-blind study of single fiber EMG changes
D J Lange, M Rubin, P E Greene, et al.
Annals of Neurology
|
September 28, 1998
Functional brain networks in DYT1 dystonia
D Eidelberg, J R Moeller, A Antonini, et al.
Nature Genetics
|
December 1, 1993
Linkage mapping of dopa-responsive dystonia (DRD) to chromosome 14q
T G Nygaard, K C Wilhelmsen, N J Risch, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
January 1, 1987
Localized injections of botulinum toxin for the treatment of focal dystonia and hemifacial spasm
M F Brin, S Fahn, C Moskowitz, et al.
Page
of 41
Search research articles
Search
Showing results (351-360 of 407) with videos related to
Sort By:
Page
of 41
Brain Research
|
September 6, 1988
Non-chromaffin tissue plus nerve growth factor reduces experimental parkinsonism in aged rats
G Pezzoli, S Fahn, A Dwork, et al.
Archives of Neurology
|
December 1, 1996
Use of intrathecal baclofen in the treatment of patients with dystonia
B Ford, P Greene, E D Louis, et al.
Advances in Neurology
|
September 29, 1998
Intrathecal baclofen in the treatment of dystonia
B Ford, P E Greene, E D Louis, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism
|
September 1, 1993
Striatal 18F-dopa uptake: absence of an aging effect
D Eidelberg, S Takikawa, V Dhawan, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
January 1, 1994
A multicenter double-blind placebo-controlled trial of pergolide as an adjunct to Sinemet in Parkinson's disease
C W Olanow, S Fahn, M Muenter, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience
|
May 1, 1992
Transgenic mice with increased Cu/Zn-superoxide dismutase activity are resistant to N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurotoxicity
S Przedborski, V Kostic, V Jackson-Lewis, et al.
Muscle & Nerve
|
July 1, 1991
Distant effects of locally injected botulinum toxin: a double-blind study of single fiber EMG changes
D J Lange, M Rubin, P E Greene, et al.
Annals of Neurology
|
September 28, 1998
Functional brain networks in DYT1 dystonia
D Eidelberg, J R Moeller, A Antonini, et al.
Nature Genetics
|
December 1, 1993
Linkage mapping of dopa-responsive dystonia (DRD) to chromosome 14q
T G Nygaard, K C Wilhelmsen, N J Risch, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
January 1, 1987
Localized injections of botulinum toxin for the treatment of focal dystonia and hemifacial spasm
M F Brin, S Fahn, C Moskowitz, et al.
Page
of 41